Warning: mkdir(): Permission denied in /home/virtual/lib/view_data.php on line 81

Warning: fopen(upload/ip_log/ip_log_2024-12.txt): failed to open stream: No such file or directory in /home/virtual/lib/view_data.php on line 83

Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 84
Comparison of gene expression profiles of human dental pulp cells treated with mineral trioxide aggregate and calcium hydroxide

Comparison of gene expression profiles of human dental pulp cells treated with mineral trioxide aggregate and calcium hydroxide

Article information

Restor Dent Endod. 2011;36(5):397-408
Publication date (electronic) : 2011 September 14
doi : https://doi.org/10.5395/JKACD.2011.36.5.397
1Program in Conservative Dentistry, Seoul National University Graduate School
2Department of Conservative Dentistry, Seoul National University School of Dentistry and Dental Research Institute, Seoul, Korea
*Correspondence to: Kwang-Shik Bae, DDS, MSD, PhD., Professor, Department of Conservative Dentistry, Seoul National University School of Dentistry, Dental Research Institute, 28-2 Yongon-dong, Jongno-gu, Seoul, Korea 110-749, Tel, +82-2-2072-2651; Fax, +82-2-2072-3859; E-mail, baeks@snu.ac.kr
Received 2011 July 20; Revised 2011 August 17; Accepted 2011 August 21.

Abstract

Abstract

Objectives:

This study investigated changes in gene expressions concerning of differentiation, proliferation, mineralization and inflammation using Human-8 expression bead arrays when white Mineral Trioxide Aggregate and calcium hydroxide-containing cement were applied in vitro to human dental pulp cells (HDPCs).

Materials and Methods:

wMTA (white ProRoot MTA, Dentsply) and Dycal (Dentsply Caulk) in a Teflon tube (inner diameter 10 mm, height 1 mm) were applied to HDPCs. Empty tube-applied HDPCs were used as negative control. Total RNA was extracted at 3, 6, 9 and 24 hr after wMTA and Dycal application. The results of microarray were confirmed by reverse transcriptase polymerase chain reaction.

Results:

Out of the 24,546 genes, 43 genes (e.g., BMP2, FOSB, THBS1, EDN1, IL11, COL10A1, TUFT1, HMOX1) were up-regulated greater than two-fold and 25 genes (e.g., SMAD6, TIMP2, DCN, SOCS2, CEBPD, KIAA1199) were down-regulated below 50% by wMTA. Two hundred thirty nine genes (e.g., BMP2, BMP6, SMAD6, IL11, FOS, VEGFA, PlGF, HMOX1, SOCS2, CEBPD, KIAA1199) were up-regulated greater than two-fold and 358 genes (e.g., EDN1, FGF) were down-regulated below 50% by Dycal.

Conclusions:

Both wMTA and Dycal induced changes in gene expressions related with differentiation and proliferation of pulp cells. wMTA induced changes in gene expressions related with mineralization, and Dycal induced those related with angiogenesis. The genes related with inflammation were more expressed by Dycal than by wMTA. It was confirmed that both wMTA and Dycal were able to induce gene expression changes concerned with the pulp repair in different ways.

Figure 1.

Classification of expressed genes by wMTA treatment. The genes which were up-or down-regulated by at least twofold following a cellular treatment with wMTA at any time point were classified using the panther classification system (http://www.pantherdb.org).

Figure 2.

Classification of expressed genes by Dycal treatment. The genes which were up-or down-regulated by at least twofold following a cellular treatment with Dycal at any time point were classified using the panther classification system.

Primer sequence list used in RT-PCR

Summary of expression profiles of genes differentially regulated by wMTA and Dycal

The relative mRNA expression levels of genes analyzed by RT-PCR

References

1. American Association of Endodontists. Glossary of endodontic terms 7th ed.th ed. p. pp40. 2003.
2. Cox CF, Su¨bay RK, Ostro E, Suzuki S, Suzuki SH. Tunnel defects in dentin bridges: their formation following direct pulp capping. Oper Dent 1996;21:4–11.
3. Cox CF, Hafez AA, Akimoto N, Otsuki M, Suzuki S, Tarim B. Biocompatibility of primer, adhesive and resin composite systems on non-exposed and exposed pulps of non-human primate teeth. Am J Dent 1998;11(Supplement):55–63.
4. Cox CF, Tarim B, Kopel H, Gu¨rel G, Hafez A. Technique sensitivity: biological factors contributing to clinical success with various restorative materials. Adv Dent Res 2001;15:85–90.
5. Yun YR, Yang IS, Hwang YC, Hwang IN, Choi HR, Yoon SJ, Kim SH, Oh WM. Pulp response of mineral trioxide aggregate, calcium sulfate or calcium hydroxide. J Kor Acad Cons Dent 2007;32:95–101.
6. Bae JH, Kim YG, Yoon PY, Cho BH, Choi YH. Pulp response of beagle dog to direct pulp capping materials: histological study. J Kor Acad Cons Dent 2010;35:5–12.
7. Dominguez MS, Witherspoon DE, Gutmann JL, Opperman LA. Histological and scanning electron microscopy assessment of various vital pulp-therapy materials. J Endod 2003;29:324–333.
8. Ford TR, Torabinejad M, Abedi HR, Bakland LK, Kariyawasam SP. Using mineral trioxide aggregate as a pulp-capping material. J Am Dent Assoc 1996;127:1491–1494.
9. Faraco IM Jr, Holland R. Response of the pulp of dogs to capping with mineral trioxide aggregate or a calcium hydroxide cement. Dent Traumatol 2001;17:163–166.
10. Hauman CH, Love RM. Biocompatibility of dental materials used in contemporary endodontic therapy: a review. Part 2. Root canal-filling materials. Int Endod J 2003;36:147–160.
11. Aeinehchi M, Eslami B, Ghanbariha M, Saffar AS. Mineral trioxide aggregate (MTA) and calcium hydroxide as pulp-capping agents in human teeth: a preliminary report. Int Endod J 2003;36:225–231.
12. Accorinte Mde L, Holland R, Reis A, Bortoluzzi MC, Murata SS, Dezan E Jr, Souza V, Alessandro LD. Evaluation of mineral trioxide aggregate and calcium hydroxide cement as pulp-capping agents in human teeth. J Endod 2008;34:1–6.
13. Iwamoto CE, Adachi E, Pameijer CH, Barnes D, Romberg EE, Jeffries S. Clinical and histological evaluation of white ProRoot MTA in direct pulp capping. Am J Dent 2006;19:85–90.
14. Yasuda Y, Ogawa M, Arakawa T, Kadowaki T, Saito T. The effect of mineral trioxide aggregate on the mineralization ability of rat dental pulp cells: an in vitro study. J Endod 2008;34:1057–1060.
15. Andelin WE, Shabahang S, Wright K, Torabinejad M. Identification of hard tissue after experimental pulp capping using dentin sialoprotein (DSP) as a marker. J Endod 2003;29:646–650.
16. Kuratate M, Yoshiba K, Shigetani Y, Yoshiba N, Ohshima H, Okiji T. Immunohistochemical analysis of nestin, osteopontin, and proliferating cells in the reparative process of exposed dental pulp capped with mineral trioxide aggregate. J Endod 2008;34:970–974.
17. Min KS, Yang SH, Kim EC. The combined effect of mineral trioxide aggregate and enamel matrix derivative on odontoblastic differentiation in human dental pulp cells. J Endod 2009;35:847–851.
18. Shi S, Robey PG, Gronthos S. Comparison of human dental pulp and bone marrow stromal stem cells by cDNA microarray analysis. Bone 2001;29:532–539.
19. McLachlan JL, Smith AJ, Bujalska IJ, Cooper PR. Gene expression profiling of pulpal tissue reveals the molecular complexity of dental caries. Biochim Biophys Acta 2005;1741:271–281.
20. Syudo M, Yamada S, Yanagiguchi K, Matsunaga T, Hayashi Y. Early gene expression analyzed by a genome microarray and real-time PCR in osteoblasts cultured with a 4-META/MMA-TBB adhesive resin sealer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;107:e77–81.
21. Martinez ZR, Naruishi K, Yamashiro K, Myokai F, Yamada T, Matsuura K, Namba N, Arai H, Sasaki J, Abiko Y, Takashiba S. Gene profiles during root canal treatment in experimental rat periapical lesions. J Endod 2007;33:936–943.
22. Yokose S, Kadokura H, Tajima Y, Fujieda K, Katayama I, Matsuoka T, Katayama T. Establishment and characterization of a culture system for enzymatically released rat dental pulp cells. Calcif Tissue Int 2000;66:139–144.
23. Kim YB, Shon WJ, Lee WC, Kum KY, Baek SH, Bae KS. Gene Expression Profiling in Human Dental Pulp Cells Treated with Mineral Trioxide Aggregate. J Kor Acad Cons Dent 35:152–163. 2010;
24. Goldberg M, Six N, Decup F, Lasfargues JJ, Salih E, Tompkins K, Veis A. Bioactive molecules and the future of pulp therapy. Am J Dent 2003;16:66–76.
25. Almushayt A, Narayanan K, Zaki AE, George A. Dentin matrix protein 1 induces cytodifferentiation of dental pulp stem cells into odontoblasts. Gene Ther 2006;13:611–620.
26. Goldberg M, Farges JC, Lacerda-Pinheiro S, Six N, Jegat N, Decup F, Septier D, Carrouel F, Durand S, Chaussain-Miller C, Denbesten P, Veis A, Poliard A. Inflammatory and immunological aspects of dental pulp repair. Pharmacol Res 2008;58:137–147.
27. Reddi AH. Bone morphogenetic proteins: an unconventional approach to isolation of first mammalian mor-phogens. Cytokine Growth Factor Rev 1997;8:11–20.
28. Gu K, Smoke RH, Rutherford RB. Expression of genes for bone morphogenetic proteins and receptors in human dental pulp. Arch Oral Biol 1996;41:919–923.
29. Nakashima M, Nagasawa H, Yamada Y, Reddi AH. Regulatory role of transforming growth factor-β, bone morphogenetic protein-2, and protein-4 on gene expression of extracellular matrix proteins and differentiation of dental pulp cells. Dev Biol 1994;162:18–28.
30. Saito T, Ogawa M, Hata Y, Bessho K. Acceleration effect of human recombinant bone morphogenetic protein-2 on differentiation of human pulp cells into odon-toblasts. J Endod 2004;30:205–208.
31. Yasuda Y, Ogawa M, Arakawa T, Kadowaki T, Saito T. The effect of mineral trioxide aggregate on the mineralization ability of rat dental pulp cells: an in vitro study. J Endod 2008;34:1057–1060.
32. Wozney JM, Rosen V. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop Relat Res 1998;346:26–37.
33. Takeda K, Oida S, Goseki M, Iimura T, Maruoka Y, Amagasa T, Sasaki S. Expression of bone morphogenetic protein genes in the human dental pulp cells. Bone 1994;15:467–470.
34. Zhang Q, Wang X, Chen Z, Liu G, Chen Z. Semi-quantitative RT-PCR analysis of LIM mineralization protein 1 and its associated molecules in cultured human dental pulp cells. Arch Oral Biol 2007;52:720–726.
35. Matsui S, Takeuchi H, Tsujimoto Y, Matsushima K. Effects of Smads and BMPs induced by Ga-Al-As laser irradiation on calcification ability of human dental pulp cells. J Oral Sci 2008;50:75–81.
36. Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M, Miyazono K. Smad6 inhibits signaling by the TGF-βsuperfamily. Nature 1997;389:622–626.
37. Lawler J. The functions of thrombospondin-1 and-2. Curr Opin Cell Biol 2000;12:634–640.
38. Murphy-Ullrich JE, Schultz-Cherry S, Ho¨o¨k M. Transforming growth factor-beta complexes with thrombospondin. Mol Biol Cell 1992;3:181–188.
39. Ueno A, Yamashita K, Nagata T, Tsurumi C, Miwa Y, Kitamura S, Inoue H. cDNA cloning of bovine thrombospondin 1 and its expression in odontoblasts and predentin. Biochim Biophys Acta 1998;1382:17–22.
40. Neuhaus SJ, Byers MR. Endothelin receptors and endothelin-1 in developing rat teeth. Arch Oral Biol 2007;52:655–662.
41. Yan Y, Liu Z, Zhang WG. In vitro study of the effects of endothelin-1 on human dental pulp cells. Chin J Dent Res 1999;2:5–13.
42. Suga K, Saitoh M, Fukushima S, Takahashi K, Nara H, Yasuda S, Miyata K. Interleukin-11 induces osteoblast differentiation and acts synergistically with bone morphogenetic protein-2 in C3H10T1/2 cells. J Interferon Cytokine Res 2001;21:695–707.
43. Takeuchi Y, Watanabe S, Ishii G, Takeda S, Nakayama K, Fukumoto S, Kaneta Y, Inoue D, Matsumoto T, Harigaya K, Fujita T. Interleukin-11 as a stimulatory factor for bone formation prevents bone loss with advancing age in mice. J Biol Chem 2002;277:49011–49018.
44. Takayanaqi H, Kim S, Koqa T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclast. Dev Cell 2002;3:889–901.
45. Grigoriadis AE, Wang ZQ, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, Wagner EF. C-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 1994;266:443–448.
46. Grigoriadis AE, Schellander K, Wang ZQ, Wagner EF. Osteoblasts are target cells for transformation in c-fos transgenic mice. J Cell Biol 1993;122:685–701.
47. Gruda MC, van Amsterdam J, Rizzo CA, Durham SK, Lira S, Bravo R. Expression of FosB during mouse development: normal development of FosB knockout mice. Oncogene 1996;12:2177–2185.
48. Smith AJ, Murray PE, Lumley PJ. Preserving the vital pulp in operative dentistry: 1. a biological approach. Dent Update 2002;29:64–69.
49. Keyt BA, Nguyen HV, Berleau LT, Duarte CM, Park J, Chen H, Ferrara N. Identification of vascular endothelial growth factor determinants for binding KDR and Flt-1 receptors: generation of receptorselective VEGF variants by site-directed mutagenesis. J Biol Chem 1996;271:5638–5646.
50. Matsushita K, Motani R, Sakuta T, Yamaguchi N, Koga T, Matsuo K, Nagaoka S, Abeyama K, Maruyama I, Torii M. The role of vascular endothelial growth factor in human dental pulp cells: induction of chemotaxis, proliferation, and differentiation and activation of the AP-1-dependent signaling pathway. J Dent Res 2000;79:1596–1603.
51. Roberts-Clark DJ, Smith AJ. Angiogenic growth factors in human dentine matrix. Arch Oral Biol 2000;45:1013–1016.
52. Ribatti D. The crucial role of vascular permeability fac-tor/vascular endothelial growth factor in angiogenesis: a historical review. Br J Haematol 2005;128:303–309.
53. Heissig B, Hattori K, Friedrich M, Rafii S, Werb Z. Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases. Curr Opin Hematol 2003;10:136–141.
54. Seo DW, Li H, Guedez L, Wingfield PT, Diaz T, Salloum R, Wei BY, Stetler-Stevenson WG. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell 2003;114:171–180.
55. Murphy AN, Unsworth EJ, Stetler-Stevenson WG. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol 1993;157:351–358.
56. Mochida Y, Duarte WR, Tanzawa H, Paschalis EP, Yamauchi M. Decorin modulates matrix mineralization in vitro. Biochem Biophys Res Commun 2003;305:6–9.
57. Alini M, Marriott A, Chen T, Abe S, Poole AR. A novel angiogenic molecule produced at the time of chondrocyte hypertrophy during endochondral bone formation. Dev Biol 1996;176:124–132.
58. Felszeghy S, Hollo′ K, Mo′dis L, Lammi MJ. Type X collagen in human enamel development: a possible role in mineralization. Acta Odontol Scand 2000;58:171–176.
59. Deutsch D, Palmon A, Fisher LW, Kolodny N, Termine JD, Young MF. Sequencing of bovine enamelin (“tuftelin”) a novel acidic enamel protein. J Biol Chem 1991;266:16021–10628.
60. Paine CT, Paine ML, Luo W, Okamoto CT, Lyngstadaas SP, Snead ML. A tuftelin-interacting protein (TIP39) localizes to the apical secretory pole of mouse ameloblasts. J Biol Chem 2000;275:22284–22292.
61. Otterbein LE, Choi AE. Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol 2000;279:L1029–1037.
62. Foresti R, Motterlini R. The heme oxygenase pathway and its interaction with nitric oxide in the control of cellular homeostasis. Free Radic Res 1999;31:459–475.
63. Min KS, Lee HJ, Kim SH, Lee SK, Kim HR, Pae HO, Chung HT, Shin HI, Lee SK, Kim EC. Hydrogen peroxide induces heme oxygenase-1 and dentin sialophos-phoprotein mRNA in human pulp cells. J Endod 2008;34:983–989.
64. Min KS, Kwon YY, Lee HJ, Lee SK, Kang KH, Lee SK, Kim EC. Effects of proinflammatory cytokines on the expression of mineralization markers and heme oxygenase-1 in human pulp cells. J Endod 2006;32:39–43.
65. Krebs DL, Hilton DJ. SOCS proteins: negative regulators of cytokine signaling. Stem Cells 2001;19:378–387.
66. Machado FS, Johndrow JE, Esper L, Dias A, Bafica A, Serhan CN, Aliberti J. Anti-inflammatory actions of lipoxin A(4) and aspirin-triggered lipoxin are SOCS-2 dependent. Nat Med 2006;12:330–334.
67. Alexander WS, Hilton DJ. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu Rev Immunol 2004;22:503–529.
68. Menezes R, Garlet TP, Trombone AP, Repeke CE, Letra A, Granjeiro JM, Campanelli AP, Garlet GP. The potential role of suppressors of cytokine signaling in the attenuation of inflammatory reaction and alveolar bone loss associated with apical periodontitis. J Endod 2008;34:1480–1484.
69. Schrem H, Klempnauer J, Borlak J. Liver-enriched transcription factors in liver fuction and development. Part II: The C/EBPs and D site binding protein in cell cycle control, carcinogenesis, circadian gene regulation, liver regulation, apoptosis, and liver-specific gene regulation. Pharmacol Rev 2004;56:291–330.
70. Liu YW, Chen CC, Wang JM, Chang WC, Huang YC, Chung SY, Chen BK, Hung JJ. Role of transcriptional factors Sp1, c-Rel, and c-Jun in LPS-induced C/EBPdelta gene expression of mouse macrophages. Cell Mol Life Sci 2007;64:3282–3294.
71. Caivano M, Gorgoni B, Cohen P, Poli V. The induction of cyclooxygenage-2 mRNA in macrophages is biphasic and requires both CCAAT/enhancer-binding protein beta (C/EBP beta) and C/EBP delta transcription factors. J Biol Chem 2001;276:48693–48701.

Article information Continued

Figure 1.

Classification of expressed genes by wMTA treatment. The genes which were up-or down-regulated by at least twofold following a cellular treatment with wMTA at any time point were classified using the panther classification system (http://www.pantherdb.org).

Figure 2.

Classification of expressed genes by Dycal treatment. The genes which were up-or down-regulated by at least twofold following a cellular treatment with Dycal at any time point were classified using the panther classification system.

Table 1.

Primer sequence list used in RT-PCR

Target gene Forward Primer Reverse Product Size (bp)
GAPDH 5′-GAA GTG GAA GGT CGG AGT C-3′   5′-GAA GAT GGT GAT GGG ATT TC-3′ 313
BMP2 5′-ACT TTT GGA CAC CAG GTT GG-3′   5′-GCT GTT TGT GTT TGG CTT GA-3′ 296
IL11 5′-GCA ATC TGA GGT CAC TGC AA-3′   5′-TCA CAG GGT GAC TTG TGG AA-3′ 300
EDN1 5′-TTC CGT ATG GAC TTG GAA GC-3′   5′-TCT CCG ACC TGG TTT GTC TT-3′ 300
CEBPD 5′-AGA AGT TGG TGG AGC TGT CG-3′   5′-CCA GGC TGT AGC TTC TTT GC-3′ 300
FOSB 5′-GGC TCA ACA AGG AAA AAT GC-3′   5′-GAG GCC AGA AAT TCC AAT CA-3′ 297
TUFT1 5′-GCA GAA AGA GGC AGA AGT CG-3′   5′-CCA AGC AGA ACG AGA AAA GG-3′ 152
FOS 5′-CTT CCT GTT CCC AGC ATC AT-3′   5′-GTC AGA GGA AGG CTC ATT GC-3′ 298
THBS1 5′-CCT GTG CTG CAG ACA TTG AT-3′   5′-GAA CAC AAT CCG GAT CAG CT-3′ 148
DCN 5′-GGA CCG TTT CAA CAG AGA GG-3′   5′-AAT GCC ATC TTC GAG TGG TC-3′ 147
BMP6 5′-TTC GTG CTG GAG TTT TGT TG-3′   5′-CTA ACC CTG TGG CGT GGT AT-3′ 298
FGF5 5′-GCA AGT GCC AAG TTC ACA GA-3′   5′-AGG TGC AGA AAG GGG AAT CT-3′ 303

Table 2.

Summary of expression profiles of genes differentially regulated by wMTA and Dycal

Fold change
Number Gene symbol
wMTA Dycal
fold > 2 fold > 2 17 NUAK1, TRIB1, SGK, FZD8, NOX4, ABCA1, SLC35F2, BPGM, IL11,
      PMEPA1, ASNS, RCAN1, BMP2, PTGS2, PTHLH, STC1, HMOX1
  fold < -2 1 EDN1
 
2 > fold > -2
25
LOH3CR2A, ANGPTL4, SH3BP5L, MMP10, DENR, DACT1, SCD, SLC46A3, UAP1L1, PDPN, FOSB, TUFT1, TNS1, ZNF365, ESM1, HBEGF, NKX3-1, MAZ, AK3L1, ETV4, MT1X, FOLR3, LRRC17, THBS1, COL10A1
 
Subtotal
43
 
fold < -2 fold > 2 7 KIAA1199, DHRS3, CEBPD, KYNU, SMAD6, ATOH8, SOCS2
fold < -2 5 PDE5A, HERC4, DDIT4L, VCAM1, SLC25A22
 
2 > fold > -2
13
TIMP2, FBN2, COL3A1, MFGE8, CNTNAP1, MFAD4, UBA7, PRRX2, VPS24, SIPA1, ASAM, PHF15, DCN
 
Subtotal
25
 

Table 3.

The relative mRNA expression levels of genes analyzed by RT-PCR

Symbol 6hr
9hr
24hr
wMTA Dycal wMTA Dycal wMTA Dycal
BMP2 1.88 2.31        
IL11     1.99 2.38    
EDN1         1.41 0.26
CEBPD         1.16 2.07
FOSB     1.28      
TUFT1     1.57      
FOS       1.77    
THBS1         1.89  
DCN         0.58  
BMP6           11.93
FGF5           0.25

The relative level of gene expression was normalized against GAPDH messenger RNA, and the control was set as 1.0. Optical density values represent the mean (n=3).